AstraZeneca diabetes drug recommended in Europe

AstraZeneca and Bristol-Myers Squibb’s new type II diabetes treatment Forxiga has received a positive opinion by European regulators.  The European Medicines Agency’s Committee for Me…
Read the full story: InPharm